To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Kimberly Giammarco thought she needed glasses. What she ...
T-knife Therapeutics Inc. has filed a clinical trial application (CTA) to initiate a phase I trial of TK-6302, a PRAME-targeted T-cell receptor (TCR) T-cell therapy in solid tumors. Pending CTA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results